Fang Fan
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
Year:
2026
Year:
2026
Year:
2026
Residual Cancer Burden (RCB) after neoadjuvant chemotherapy (NAC) is validated to predict event-free survival (EFS) in breast cancer but has not been studied for invasive lobular carcinoma (ILC). We studied patient-level data from a pooled cohort across 12 institutions. Associations between RCB index, class, and EFS were assessed in ILC and non-ILC with mixed effect Cox models and multivariable analyses. Recursive partitioning was used in an exploratory model to stratify prognosis by RCB components. Of 5106 patients, the diagnosis was ILC in 216 and non-ILC in 4890. Increased RCB index was associated with worse EFS in both ILC and non-ILC ( p = 0.002 and p < 0.001, respectively) and remained prognostic when stratified by receptor subtype and adjusted for age, grade, T category, and nodal status. Recursive partitioning demonstrated residual invasive cancer cellularity as most prognostic in ILC. These results underscore the utility of RCB for evaluating NAC response in those with ILC.
Year:
2025
Year:
2025
Year:
2025
Year:
2023
Year:
2021
Year:
2020
Collaborators (6)
Min Han
Assistant Clinical Professor
City Of Hope National Medical Center
Sara Lopez-Tarruella
ASSOCIATE PROFESSOR
Universidad Complutense de Madrid
Jean Abraham
Professor of Precision Breast Cancer Medicine
University of Cambridge
Marick Laé
-
Laura Esserman
University of California
Rita A. Mukhtar
Professor of Surgery
University of California
Make your next move.
Prepare your application
Review drafts before you send them.